An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation

FASEB Journal

Volumn 25, Issue 4, 2011, Pages 1323-1332

  Rauch, Alexander ^a   Gossye, Valerie ^b   Bracke, Debby ^b   Gevaert, Elien ^b   Jacques, Peggy ^c   Van Beneden, Katrien ^c   Vandooren, Bernard ^c   Rauner, Martina ^d   Hofbauer, Lorenz C ^d   Haegeman, Guy ^b   Elewaut, Dirk ^b   Tuckermann, Jan P ^a,b   De Bosscher, Karolien ^b  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

GR; Interleukin 11; Osteoporosis

Indexed keywords

ANTIINFLAMMATORY AGENT; COMPOUND A; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 11; OSTEOCLAST DIFFERENTIATION FACTOR; PLANT EXTRACT; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIMERIZATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZIRIDINES; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-11; MALE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; PLANT EXTRACTS; RANK LIGAND; RECEPTORS, GLUCOCORTICOID;

EID: 79954592084     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-173393     Document Type: Article

References (47)

1. Rosen, J., and Miner, J. N. (2005) The search for safer glucocorticoid receptor ligands. Endocr. Rev. 26, 452-464 (Pubitemid 40691300)
2. Berris, K. K., Repp, A. L., and Kleerekoper, M. (2007) Glucocorticoid-induced osteoporosis. Curr. Opin. Endocrinol. Diabetes Obes. 14, 446-450 (Pubitemid 350214011)
3. Schett, G., Saag, K. G., and Bijlsma, J. W. J. (2010) From bone biology to clinical outcome: state of the art and future perspectives. Ann. Rheum. Dis. 69, 1415-1419
4. Pratt, W. B., and Toft, D. O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306-360 (Pubitemid 27246880)
5. Beck, I. M., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., and De Bosscher, K. (2009) Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr. Rev. 30, 830-882
6. De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., and Haegeman, G. (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. U. S. A. 94, 13504-13509 (Pubitemid 28009612)
7. Nissen, R. M., and Yamamoto, K. R. (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329
8. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522 (Pubitemid 37059110)
9. Gossye, V., Haegeman, G., and De Bosscher, K. (2008) Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk. Front. Biosci. 13, 4122-4143 (Pubitemid 351599679)
10. Canalis, E., Mazziotti, G., Giustina, A., and Bilezikian, J. P. (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18, 1319-1328 (Pubitemid 47389469)
11. Jia, D., O'Brien, C. A., Stewart, S. A., Manolagas, S. C., and Weinstein, R. S. (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147, 5592-5599 (Pubitemid 44833476)
12. Swanson, C., Lorentzon, M., Conaway, H. H., and Lerner, U. H. (2006) Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinology 147, 3613-3622 (Pubitemid 43901154)
13. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282 (Pubitemid 28335186)
14. Smith, E., Redman, R. A., Logg, C. R., Coetzee, G. A., Kasahara, N., and Frenkel, B. (2000) Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J. Biol. Chem. 275, 19992-20001 (Pubitemid 30441607)
15. Rauch, A., Seitz, S., Baschant, U., Schilling, A. F., Illing, A., Stride, B., Kirilov, M., Mandic, V., Takacz, A., Schmidt-Ullrich, R., Ostermay, S., Schinke, T., Spanbroek, R., Zaiss, M. M., Angel, P. E., Lerner, U. H., David, J.-P., Reichardt, H. M., Amling, M., Schütz, G., and Tuckermann, J. P. (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11, 517-531
16. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz, G. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541 (Pubitemid 28240715)
17. Frijters, R., Fleuren, W., Toonen, E. J. M., Tuckermann, J. P., Reichardt, H. M., van der Maaden, H., van Elsas, A., van Lierop, M.-J., Dokter, W., de Vlieg, J., and Alkema, W. (2010) Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics 11, 359
18. Baschant, U., and Tuckermann, J. (2010) The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120, 69-75
19. Dewint, P., Gossye, V., De Bosscher, K., Vanden Berghe, W., Van Beneden, K., Deforce, D., Van Calenbergh, S., Müller-Ladner, U., Vander Cruyssen, B., Verbruggen, G., Haegeman, G., and Elewaut, D. (2008) A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J. Immunol. 180, 2608-2615
20. De Bosscher, K., Vanden Berghe, W., Beck, I. M., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., and Haegeman, G. (2005) A fully dissociated compound of plant origin for inflammatory gene repression. Proc. Natl. Acad. Sci. U. S. A. 102, 15827-15832 (Pubitemid 41552827)
21. Wüst, S., Tischner, D., John, M., Tuckermann, J. P., Menzfeld, C., Hanisch, U.-K., van den Brandt, J., Lühder, F., and Reichardt, H. M. (2009) Therapeutic and adverse effects of a nonsteroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PLoS ONE 4, e8202
22. Van Loo, G., Sze, M., Bougarne, N., Praet, J., McGuire, C., Ullrich, A., Haegeman, G., Prinz, M., Beyaert, R., and De Bosscher, K. (2009) Anti-inflammatory properties of a plantderived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis. Mol. Endocrinol., 24, 1-13
23. Zhang, Z., Zhang, Z. Y., and Schluesener, H. J. (2009) Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J. Immunol. 183, 3081-3091
24. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., Medsger, T. A., Jr., Mitchell, D. M., Neustadt, D. H., Pinals, R. S., Schaller, J. G., Sharp, J. T., Wilder, R. L., and Hunder, G. G. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324 (Pubitemid 18091653)
25. Gossye, V., Elewaut, D., Bougarne, N., Bracke, D., Van Calenbergh, S., Haegeman, G., and De Bosscher, K. (2009) Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60, 3241-3250
26. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
27. Trepicchio, W. L., and Dorner, A. J. (1998) Interleukin-11. A gp130 cytokine. Ann. N. Y. Acad. Sci. 856, 12-21 (Pubitemid 28517332)
28. Schäcke, H., Berger, M., Hansson, T. G., McKerrecher, D., and Rehwinkel, H. (2008) Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compounds. Expert Opin. Ther. Patents 18, 339-352 (Pubitemid 351577865)
29. Schäcke, H., Berger, M. H. R., and Asadullah, K. (2007) Selective Glucocorticoid Receptor Agonists (SEGRAs): Novel ligands with an improved therapeutic index. Mol. Cell. Endocrinol. 275, 109-117 (Pubitemid 47259282)
30. Müller-Ladner, U., Kriegsmann, J., Franklin, B. N., Matsumoto, S., Geiler, T., Gay, R. E., and Gay, S. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149, 1607-1615 (Pubitemid 26363967)
31. Smith, T. J. (2005) Insights into the role of fibroblasts in human autoimmune diseases. Clin. Exp. Immunol. 141, 388-397 (Pubitemid 41075861)
32. Müller-Ladner, U., Gay, R. E., and Gay, S. (2000) Activation of synoviocytes. Curr. Opin. Rheumatol. 12, 186-194 (Pubitemid 30238386)
33. Pap, T., Meinecke, I., Müller-Ladner, U., and Gay, S. (2005) Are fibroblasts involved in joint destruction? Ann. Rheum. Dis. 64 (Suppl. 4), iv52-iv54 (Pubitemid 41532019)
34. Hou, W. S., Li, Z., Gordon, R. E., Chan, K., Klein, M. J., Levy, R., Keysser, M., Keyszer, G., and Bromme, D. (2001) Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am. J. Pathol. 159, 2167-2177 (Pubitemid 33104271)
35. Seitz, M., Loetscher, P., Fey, M. F., and Tobler, A. (1994) Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br. J. Rheumatol. 33, 613-619 (Pubitemid 24222111)
36. Shigeyama, Y., Pap, T., Kunzler, P., Simmen, B. R., Gay, R. E., and Gay, S. (2000) Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum. 43, 2523-2530
37. Gossye, V., Elewaut, D., Van Beneden, K., Dewint, P., Haegeman, G., and De Bosscher, K. (2010) A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance. Ann. Rheum. Dis. 69, 291-296
38. Kondo, T., Kitazawa, R., Yamaguchi, A., and Kitazawa, S. (2008) Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J. Cell. Biochem. 103, 335-345
39. Hofbauer, L. C., and Heufelder, A. E. (1999) Osteopetrosis in cathepsin K-deficient mice. Eur. J. Endocrinol. 140, 376-377 (Pubitemid 29254000)
40. Kim, H. J., Zhao, H., Kitaura, H., Bhattacharyya, S., Brewer, J. A., Muglia, L. J., Ross, F. P., and Teitelbaum, S. L. (2006) Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116, 2152-2160 (Pubitemid 44162324)
41. Coghlan, M. J., Jacobson, P. B., Lane, B., Nakane, M., Lin, C. W., Elmore, S. W., Kym, P. R., Luly, J. R., Carter, G. W., Turner, R., Tyree, C. M., Hu, J., Elgort, M., Rosen, J., and Miner, J. N. (2003) A novel anti-inflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17, 860-869 (Pubitemid 36546214)
42. Humphrey, E. L., Williams, J. H., Davie, M. W., and Marshall, M. J. (2006) Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38, 652-661
43. Rauner, M., Goettsch, C., Stein, N., Thiele, S., Bornhaeuser, M., De Bosscher, K., Haegeman, G., Tuckermann, J., and Hofbauer, L. C. (2011) Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 152, 103-112
44. Zhou, H., Mak, W., Zheng, Y., Dunstan, C. R., and Seibel, M. J. (2008) Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J. Biol. Chem. 283, 1936-1945
45. Kalak, R., Zhou, H., Street, J., Day, R. E., Modzelewski, J. R., Spies, C. M., Liu, P. Y., Li, G., Dunstan, C. R., and Seibel, M. J. (2009) Endogenous glucocorticoid signaling in osteoblasts is necessary to maintain normal bone structure in mice. Bone 45, 61-67
46. Itoh, S., Udagawa, N., Takahashi, N., Yoshitake, F., Narita, H., Ebisu, S., and Ishihara, K. (2006) A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 39, 505-512 (Pubitemid 44149269)
47. Tohjima, E., Inoue, D., Yamamoto, N., Kido, S., Ito, Y., Kato, S., Takeuchi, Y., Fukumoto, S., and Matsumoto, T. (2003) Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice. J. Bone Miner. Res. 18, 1461-1470 (Pubitemid 41070800)